Full Press Release Details
TARRYTOWN, N.Y.,Nov. 3, 2014/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will webcast management presentations at the following investor conferences:
• Credit Suisse 2014 Healthcare Conference at12:30 p.m. Eastern Time(10:30 a.m. Mountain Time) onTuesday, November 11, 2014
• Deutsche Bank 2014 BioFEST at7:30 a.m. Eastern TimeonMonday, December 1, 2014
• Piper Jaffray26thAnnual Healthcare Conference at8:30 a.m. Eastern TimeonWednesday, December 3, 2014
The sessions may be accessed through the Company's web site,www.regeneron.com, on the 'Events and Presentations' page. Archived versions of the presentations will be available for 30 days.
About Regeneron PharmaceuticalsRegeneron is a leading science-based biopharmaceutical company based inTarrytown, New Yorkthat discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, colorectal cancer, and a rare inflammatory condition, and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis. For additional information about the company, please visitwww.regeneron.com.
| Contact Information: | |
| Manisha Narasimhan, Ph.D. | Hala Mirza |
| Investor Relations | Corporate Communications |
| 914.847.5126 | 914.847.3422 |
| [email protected] | [email protected] |